Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor

NCT07673107 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Upper Limb Essential Tremor

Interventions

DRUG: AGN-151607-DP
DRUG: Placebo for AGN-151607-DP

Sponsor

AbbVie